These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34860822)

  • 21. Clinical significance of serum survivin in patients with pancreatic ductal adenocarcinoma.
    Ren YQ; Zhang HY; Su T; Wang XH; Zhang L
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3063-8. PubMed ID: 25392106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.
    Moniaux N; Chakraborty S; Yalniz M; Gonzalez J; Shostrom VK; Standop J; Lele SM; Ouellette M; Pour PM; Sasson AR; Brand RE; Hollingsworth MA; Jain M; Batra SK
    Br J Cancer; 2008 May; 98(9):1540-7. PubMed ID: 18392050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential MicroRNA Expression Profiles as Potential Biomarkers for Pancreatic Ductal Adenocarcinoma.
    Zhu Y; Wang J; Wang F; Yan Z; Liu G; Ma Y; Zhu W; Li Y; Xie L; Bazhin AV; Guo X
    Biochemistry (Mosc); 2019 May; 84(5):575-582. PubMed ID: 31234772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Levels of Tumor Markers in Pancreatic Neuroendocrine Carcinoma and Their Values in Differentiation Between Pancreatic Neuroendocrine Carcinoma and Pancreatic Ductal Adenocarcinoma.
    Zhuge X; Guo C; Chen Y; Feng L; Jia R; Zhao Y; Sun K; Wang Z; Chen X
    Pancreas; 2018; 47(10):1290-1295. PubMed ID: 30308534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
    Halbrook CJ; Lyssiotis CA
    Cancer Cell; 2017 Jan; 31(1):5-19. PubMed ID: 28073003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma.
    Pang Y; Holmes MV; Chen Z; Kartsonaki C
    J Gastroenterol Hepatol; 2019 Feb; 34(2):330-345. PubMed ID: 30550622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers screening between preoperative and postoperative patients in pancreatic cancer.
    Li P; Yang J; Ma QY; Wu Z; Huang C; Li XQ; Wang Z
    Asian Pac J Cancer Prev; 2013; 14(7):4161-5. PubMed ID: 23991970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer.
    Dong D; Jia L; Zhang L; Ma N; Zhang A; Zhou Y; Ren L
    Cancer Sci; 2018 Sep; 109(9):2841-2851. PubMed ID: 29945294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.
    Maker AV; Carrara S; Jamieson NB; Pelaez-Luna M; Lennon AM; Dal Molin M; Scarpa A; Frulloni L; Brugge WR
    J Am Coll Surg; 2015 Feb; 220(2):243-53. PubMed ID: 25592469
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.
    Song J; Sokoll LJ; Pasay JJ; Rubin AL; Li H; Bach DM; Chan DW; Zhang Z
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):174-182. PubMed ID: 30333219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Yu J; Ploner A; Kordes M; Löhr M; Nilsson M; de Maturana MEL; Estudillo L; Renz H; Carrato A; Molero X; Real FX; Malats N; Ye W
    Int J Cancer; 2021 Apr; 148(8):2048-2058. PubMed ID: 33411965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification.
    Lindgaard SC; Sztupinszki Z; Maag E; Chen IM; Johansen AZ; Jensen BV; Bojesen SE; Nielsen DL; Hansen CP; Hasselby JP; Nielsen KR; Szallasi Z; Johansen JS
    Clin Cancer Res; 2021 May; 27(9):2592-2603. PubMed ID: 33737308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas.
    Shimamura T; Sakamoto M; Ino Y; Shimada K; Kosuge T; Sato Y; Tanaka K; Sekihara H; Hirohashi S
    Clin Cancer Res; 2002 Aug; 8(8):2570-5. PubMed ID: 12171885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma.
    Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Morimura R; Hirajima S; Okajima W; Ohashi T; Imamura T; Konishi H; Shiozaki A; Ikoma H; Okamoto K; Taniguchi H; Otsuji E
    Expert Opin Biol Ther; 2015 Jun; 15(6):773-85. PubMed ID: 25819175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.
    Yoneyama T; Ohtsuki S; Honda K; Kobayashi M; Iwasaki M; Uchida Y; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Huang W; Yamada T; Tachikawa M; Terasaki T
    PLoS One; 2016; 11(8):e0161009. PubMed ID: 27579675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy.
    Yang KS; Im H; Hong S; Pergolini I; Del Castillo AF; Wang R; Clardy S; Huang CH; Pille C; Ferrone S; Yang R; Castro CM; Lee H; Del Castillo CF; Weissleder R
    Sci Transl Med; 2017 May; 9(391):. PubMed ID: 28539469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers, imaging and multifocality in intraductal papillary mucinous neoplasms: relevant for decision making?
    Ansari D; Aronsson L; Andersson R
    Future Oncol; 2017 Aug; 13(20):1751-1753. PubMed ID: 28831817
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinoma.
    Mustafa S; Pan L; Marzoq A; Fawaz M; Sander L; Rückert F; Schrenk A; Hartl C; Uhler R; Yildirim A; Strobel O; Hackert T; Giese N; Büchler MW; Hoheisel JD; Alhamdani MS
    Oncotarget; 2017 Feb; 8(7):11963-11976. PubMed ID: 28060763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Symptoms, clinical findings and laboratory data in the pancreatic ductal adenocarcinoma].
    Hatori T; Doi M; Yamamoto M
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():106-9. PubMed ID: 25856995
    [No Abstract]   [Full Text] [Related]  

  • 40. Protein biomarker for pancreatic ductal adenocarcinoma.
    Burki T
    Lancet Oncol; 2017 Sep; 18(9):e511. PubMed ID: 28736187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.